alpha 7 nicotinic acetylcholine receptor positive allosteric modulators (CoMentis)

N/A

Report date: 2025/03/14 16:53:57
NME

Base Information

Drug Namealpha 7 nicotinic acetylcholine receptor positive allosteric modulators (CoMentis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpharmagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlpharmagen Inc
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A